Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs

Twark, L; Dodds, W J

doi:10.2460/javma.2000.217.1021

Cited by 73 publications

(63 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Earlier works by , Twark and Dodds (2000) and Eghafona et al, (2007) reported that sex, age and breed showed no significant association (where P > 0.05) with CDV serum antibody titer. This is also in agreement with what was reported in the literatures Waner and Keren-Kornblatt, 2006) but disagreed with Babalola et al (2015) who reported that gender affected the susceptibility of dogs to canine distemper.…”

Section: Discussionmentioning

confidence: 78%

“…Reports have revealed that, vaccine failure can result from the effect of maternally derived antibody or passively acquired antibodies at time of vaccination, delay in maturation of the immune system, poor vaccinal immunogenicity, genetic inability to respond to certain vaccine antigens, immune-suppression and ineffective lots of vaccine (Schultz, 2000;. It has also been reported that some dogs never appeared to mount an adequate antibody response to vaccination (Twark and Dodds, 2000). If however, there is low antibody response to vaccination due to vaccination failure, revaccination may be required.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Evaluation of Antibody Titre of Dogs Vaccinated against Canine Distemper in Jos, Plateau State

Ogbu

Anyika²,

Gosomji³

et al. 2016

Preprint

View full text Add to dashboard Cite

Determination of antibody titre of dogs vaccinated against canine distemper in Jos North and South local Government Areas of Plateau State was carried out by collection of sera of vaccinated dogs and administration of well-structured questionnaires to dog owners. The samples collected were analyzed using the immune-blot ELISA Kit to determining the antibody titre (immunoglobulin G). It indicated that dogs vaccinated against the disease mounted adequate protective immunity. The result revealed that 54 (90.0%) of the sampled dogs have protective immunity, with those given more than one dose having higher level of protective antibody. Statistically, the result showed that the antibody titre did not differ significantly in relation to immunity and sex, breed, age and location but significant difference was seen in relation to number of primary vaccination. The result also revealed that those dogs that received booster doses (secondary vaccination) had more protective antibody. The study was aimed at evaluating the antibody titre of dogs vaccinated against canine distemper in Jos, Plateau State.

show abstract

Section: Discussionmentioning

confidence: 78%

Section: Discussionmentioning

confidence: 99%

Evaluation of Antibody Titre of Dogs Vaccinated against Canine Distemper in Jos, Plateau State

Ogbu

Anyika²,

Gosomji³

et al. 2016

Preprint

View full text Add to dashboard Cite

show abstract

“…[4][5][6][8][9][10] The need for a reliable, affordable, and standardized serum antibody assay has been proposed. 9,10 In response to this idea, this study evaluated the usefulness of a commercially available standardized in-clinic dot-ELISA test kit for the semiquantitative assay of CPV and CDV IgG antibodies in dogs that had not been vaccinated for at least one year. To the authors' knowledge, this is the first study to test the applicability of an in-clinic dot-ELISA assay for the assessment of immune status in adult dogs after vaccination.…”

mentioning

confidence: 99%

Application of a Dot Enzyme-Linked Immunosorbent Assay for Evaluation of the Immune Status to Canine Parvovirus and Distemper Virus in Adult Dogs before Revaccination

2006

View full text Add to dashboard Cite

Abstract. A growing body of literature has been published indicating that the current practice of annual vaccination of dogs may not be beneficial and in some cases may even be harmful. A number of publications have proposed assessing the immune status of dogs before annual revaccination. In this study the usefulness of a commercially available dot-ELISA kit was evaluated to determine the duration IgG antibody titers to canine parvovirus (CPV) and canine distemper virus (CDV) in 158 dogs vaccinated at least one year ago. Overall, the percentage of dogs with protective antibody titers to both CPV and CDV was 84%. The percentage of dogs with borderline antibody titers was 11% for CPV and 10% for CDV. Four percent of the dogs had no detectable antibody to CPV and 6% had no antibody to CDV. The results reported here are in good agreement with other studies measuring IgG antibody levels. It is concluded that the kit offers veterinarians the opportunity of determining antibody titers and revaccinating only those pets whose antibody titers to specific diseases have waned.

show abstract

“…Σήμερα υπάρχει πληθώρα επιστημονικών δεδομένων που δείχνουν ότι η διάρκεια της ανοσίας που προ σφέρουν τα ελαττωμένης λοιμογόνου δύναμης (ΕΛΔ) απαραίτητα εμβόλια υπερβαίνει κατά πολύ τα 3 χρό νια. Συγκεκριμένα, τα εμβόλια για τον παρβοϊό (του σκύλου και της γάτας), τον ιό της νόσου του Carré και τον αδενοϊό-2 προσφέρουν ανοσία με διάρκεια 7 τουλάχιστον χρόνων (Scott and Geissinger 1999, Twark and Dodds 2000, Lappin et al 2002, Gill et al 2004, Abdelmagid et al 2004, Böhm M et al 2004, Mouzin et al 2004a, Mouzin et al 2004b, Schultz 2006, Larson and Schultz 2007, Day et al 2010a, ενώ εκείνα για τον ερπητοϊό-1, τον καλυκοϊό και τον ιό της λύσσας 3 τουλάχιστον χρόνων (Scott and Geissinger 1999, Gore et al 2006, Day et al 2010a. Αντίθετα, η διάρκεια της ανοσίας που προ σφέρουν τα προαιρετικά εμβόλια κυμαίνεται γύρω στον ένα χρόνο.…”

Section: οι κυριοτερες αλλαγες στα εμβολιακα προγραμματα του σκυλου κunclassified

New vaccination protocols for the dog and cat: the challenge of today for a better and safer prevention

Mylonakis

Koutinas

Saridomichelakis

et al. 2017

J Hellenic Vet Med Soc

View full text Add to dashboard Cite

Vaccinations are an integral part of a comprehensive preventive health care program targeting to minimize the incidence of major canine and feline infectious diseases. Currently, vaccination practices are re-evaluated globally towards a twofold objective: to strengthen "herd immunity", which depends on the percentage of vaccinated animals in a population, and to reduce the "vaccine load" per animal in order to minimize the vaccine-associated adverse reactions. To this end, the updated canine and feline vaccination guidelines, encourage the vaccination of as many animals as possible, while at the same time classify the vaccines into core, non-core and not recommended. Core vaccines should be administered, if possible, to every dog and cat.Canine parvovirus-2, canine adenovirus-2, canine distemper virus, feline parvovirus, feline calicivirus/herpesvirus-1 and rabies vaccines fall into this category. Non-core vaccines are selectively given to dogs and cats after assessing the risk/benefit ratio. There are also vaccines for which there is currently no sufficient scientific evidence to justify their use. Importantly, after the one-year booster inoculation that follows the completion of the initial puppy/kitten vaccination series, core vaccines should be given no more frequently than every three years, as the duration of the protective immunity far exceeds this time interval. This review focuses on the updated canine and feline vaccination guidelines pertaining to the individual animal as well as to those living in groups. Important questions related to vaccination programs and to relevant adverse reactions are also answered. An effort has been made to align these guidelines according to what is considered a "norm" among the small amimal practitioners in Greece.

show abstract

Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs

Abstract: The high prevalence of adequate antibody responses (CPV, 95.1%; CDV, 97.6%) in this large population of dogs suggests that annual revaccination against CPV and CDV may not be necessary.

Cited by 73 publications

References 15 publications

Evaluation of Antibody Titre of Dogs Vaccinated against Canine Distemper in Jos, Plateau State

Evaluation of Antibody Titre of Dogs Vaccinated against Canine Distemper in Jos, Plateau State

Application of a Dot Enzyme-Linked Immunosorbent Assay for Evaluation of the Immune Status to Canine Parvovirus and Distemper Virus in Adult Dogs before Revaccination

New vaccination protocols for the dog and cat: the challenge of today for a better and safer prevention

Contact Info

Product

Resources

About